Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Paper
  • Published:

Cell Culture Derived Recombinant HBsAg is Highly Immunogenic and Protects Chimpanzees from Infection with Hepatitis B Virus

Abstract

Recombinant hepatitis B surface antigen (rHBsAg) particles, secreted from Chinese hamster ovary (CHO) cells stably transfected with the S gene of HBV, are indistinguishable antigenically from HBsAg particles derived from the plasma of patients chronically infected with hepatitis B virus (HBV). The recombinant vaccine containing CHO cell derived rHBsAg is more immunogenic in chimpanzees than previously reported vaccines of either plasma derived HBsAg or yeast derived rHBsAg based on the kinetics of antibody production and the maximum titers elicited. In addition, chimpanzees vaccinated with CHO cell–culture derived vaccine have a strong cellular immune response to rHBsAg as measured by cell proliferation assays. Animals vaccinated with cell culture derived rHBsAg (ad subtype) are protected from infection with both the ad and ay subtypes of HBV.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. McAuliffe, V.J., Purcell, R.H., and Gerin, J.L. 1980. Type B Hepatitis: A review of current prospects for a safe and effective vaccine. Rev. Infec. Dis. 2:470–492.

    Article  CAS  Google Scholar 

  2. Szmuness, W., Stevens, C.E., Zang, E.A., Harley, E.J. Kellner, A. 1981. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): A final report. Hepatology 1:377.

    Article  CAS  Google Scholar 

  3. Francis, D.P., Hadler, S.C., Thompson, S.E., Maynard, et al. 1982. Prevention of Hepatitis B with Vaccine: Report of the Centers for Disease control multi-center efficacy trial among homosexual men. 97:362–366.

  4. Valenzuela, P., Medina, A., Rutter, W.J., Ammerer, G., and Hall, B.D., 1982. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298:347–350.

    Article  CAS  Google Scholar 

  5. Hitzeman, R.A., Chen, C.Y., Hagie, F.E., Patzer, et al. 1983. Expression of hepatitis B virus surface antigen in yeast. Nuc. Acids Res. 11:2745–2763.

    Article  CAS  Google Scholar 

  6. Moriarty, A.M., Hoyer, B.H., Shih, J.W., Gerin, J.L., and Hamer, D.H. 1981. Expression of the hepatitis B virus surface antigen gene in cell culture by using a simian virus 40 vector. Proc. Natl. Acad. Sci., USA 78:2606–2610.

    Article  CAS  Google Scholar 

  7. Pourcel, C., Sobzack, E., Dubois, M-F., Gervais, M., Drouet, J., and Tiollais, P. 1982. Antigenicity and immunogenicity of hepatitis B virus particles produced by mouse cells transfected with cloned viral DNA. Virol. 121:175–183.

    Article  CAS  Google Scholar 

  8. Liu, C.C., Yansura, D., and Levinson, A.D. 1982. Direct expression of hepatitis B surface antigen in monkey cells from an SV40 vector. DNA 1:213–221.

    Article  CAS  Google Scholar 

  9. Dubois, M.F., Pourcel, C., Rousset, S., Chany, C., and Tiollais, P. 1980. Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA. Proc. Natl. Acad. Sci. USA 77:4549–4553.

    Article  CAS  Google Scholar 

  10. Christman, J.K., Gerber, M., Price, P.M., Flordellis, C., Edelman, J., and Acs, G. 1982. Amplification of expression of hepatitis B surface antigen in 3T3 cells cotransfected with a dominant-acting gene and cloned viral DNA. Proc. Natl. Acad. Sci. USA 79:1815–1819.

    Article  CAS  Google Scholar 

  11. Michel, M-L., Sobczak, E., Malpiece, Y., Tiollais, P., and Streek, R.E. 1985. Expression of amplified hepatitis B virus surface antigen genes in Chinese Hamster Ovary cells. BioTechnology 3:561–566.

    CAS  Google Scholar 

  12. Fujisawa, T., Ito, Y., Sasada, R., Ono, Y. et al. 1983. Direct expression of hepatitis B surface antigen gene in E. coli. Nuc. Acids Res. 11:3581–3591.

    Article  CAS  Google Scholar 

  13. Patzer, E.J., Gregory, T.J., Nakamura, G.R., Simonsen, C.C. et al. 1985. Recombinant hepatitis B surface antigen vaccine from a continuous cell line, p. 261–264. Vaccines 85; In: Molecular and Chemical Basis of Resistance to Parasitic, Bacterial, and Viral Disease. Lerner and Chanock (eds.), Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.

    Google Scholar 

  14. Patzer, E.J., Gregory, T.J., Nakamura, G.R., Hershberg, R.D., Gregory, T.J., and Levinson, A.D. 1984. Characterization of recombinant-derived hepatitis B surface antigen secreted by a continuous cell line, pp. 477–485. In: Viral Hepatitis and Liver Disease. Vyas, Dienstag and Hoofnagel (eds.). Grune and Stratton, Inc., Orlando, FL.

    Google Scholar 

  15. Urlaub, G., and Chasin, L.A. 1980. Isolation of Chinese Hamster cell mutants deficient in dihydrofolate reductase activity. Proc. Natl. Acad. Sci., USA 77:4216–4220.

    Article  CAS  Google Scholar 

  16. Simonsen, C.C., and Levinson, A.D. 1983. Isolation and expression of an altered mouse dihydrofolate reductase cDNA. Proc. Natl. Acad. Sci., USA 80:2495–2499.

    Article  CAS  Google Scholar 

  17. Cupps, T.R., Gerin, J.L., Purcell, R.H., Goldsmith, P.K., and Fauci, A.S. 1984. In vitro antigen-induced antibody responses to hepatitis B surface antigen in man: kinetic and cellular requirements. J. Clin. Invest. 74:1204–1213.

    Article  CAS  Google Scholar 

  18. Celis, E., Kung, P.C., Chang, T.W. 1984. Hepatitis B virus-reactive human T lymphocyte clones: antigen specificity and helper function for antibody synthesis. J. Immunol. 132:1511–1515.

    CAS  PubMed  Google Scholar 

  19. Tabor, E., Purcell, R.H., London, W.T., and Gerety, R.J. 1983. Use of and interpretation of results using inocula of hepatitis B virus with known infectivity titers. J. Infect. Dis. 147:531–534.

    Article  CAS  Google Scholar 

  20. Brotman, B., Prince, A.M., Huima, T., Richardson, L., van den Ende, M.C., and Pfeifer, U. 1983. Interference between non-A, non-B and hepatitis B virus infection in chimpanzees. J. Med. Virol. 11:191–205.

    Article  CAS  Google Scholar 

  21. Hollinger, F.B., Dolana, G., Thomas, W., and Gyorkey, F. 1984. Reduction in risk of hepatitis transmission by heat-treatment of a human factor VIII concentrate. J. Infect. Dis. 150:250–262.

    Article  CAS  Google Scholar 

  22. Hilleman, M.R., Buynak, E.B., McAleer, W.J., McLean, A.A., Provost, P.J., and Tytell, A.A. 1981. Hepatitis A and hepatitis B vaccines, p. 385–397. In: Viral Hepatitis 1981 International Symposium. Szmuness, Alter and Maynard (eds.). The Franklin Press.

    Google Scholar 

  23. Imai, M., Yanase, Y., Nojiri, T., Miyakawa, Y., and Mayumi, M. 1979. Gastroenterology 76:242.

    CAS  PubMed  Google Scholar 

  24. Machida, A., Kishimoto, S., Ohnuma, H., Baba, K. et al. 1984. A polypeptide containing 55 amino acid residues coded by the pre-S region of hepatitis B virus deoxyribonucleic acid bears the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology 86:910–918.

    CAS  PubMed  Google Scholar 

  25. McAleer, W.J., Buynak, E.B., Maigetter, R.Z., Wampler, D.E., Miller, W.J., and Hilleman, M.R. 1984. Human hepatitis B vaccine from recombinant yeast. Nature 307:178–180.

    Article  CAS  Google Scholar 

  26. Chang, T.W., Celis, E., Miller, R.W., Zurawaski, Jr., V.R., Kung, P.C. 1984. In vitro response to HBsAg of peripheral blood lymphocytes from recipients of hepatitis B vaccine. Hepatology 4:824–829.

    Article  CAS  Google Scholar 

  27. Gerety, R.J., Tabor, E., Purcell, R.H., and Tyeryar, F.J. 1979. From the National Institute of Allergy and Infectious Diseases: Summary of an international workshop on hepatitis B vaccine. J. Inf. Dis. 140:642–648.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patzer, E., Nakamura, G., Hershberg, R. et al. Cell Culture Derived Recombinant HBsAg is Highly Immunogenic and Protects Chimpanzees from Infection with Hepatitis B Virus. Nat Biotechnol 4, 630–636 (1986). https://doi.org/10.1038/nbt0786-630

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0786-630

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing